Big Pharma
Coverage of Big Pharma in the Nexus archive.
- Incyte strikes up to $2bn deal for blood disorder biotech
Incyte has agreed to a potential $2 billion deal for a biotech company specializing in blood disorders. Mid-sized drug manufacturers are enhancing their pipelines and increasing competition with major pharmaceutical companies.
- ‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid
Biotech mergers and acquisitions in 2026 are experiencing a strong start, driven by patent cliffs, rising public market confidence, and pharmaceutical companies seeking to enhance their drug pipelines.
- Dozens of MPs oppose Streeting’s new power to say what NHS pays for drugs
Health Secretary Wes Streeting faces opposition from 31 MPs over granting himself authority to override Nice's drug pricing decisions for the NHS. Critics argue the move may be illegal and favor pharmaceutical companies.
- Fitness guru Jillian Michaels opens up about skipping school for Taco Bell runs during food addiction
Fitness guru Jillian Michaels discussed her past food addiction, including skipping school for Taco Bell meals, and her advocacy against processed foods. She highlighted lobbying groups like Big Ag and Big Food as barriers to health reform.